Cephazolin
PreclinicalSmall molecule
Cephazolin is one of 30 small molecule programs targeting Antibiotic Prophylaxis. It is currently in Preclinical.
2
Indications
2
Total Trials
0
Active Trials
29
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
18 competitors in Amputation
#DrugCompanyPhaseTrials
1Acanya
PfizerApproved
Flagyl
DDePuy Orthopaedics
Approved
Ansaid
PPharmacia and Upjohn
Approved
Peridex
DDexcel Pharma Technologies Ltd.
Approved
Marcaine
IInnocoll
Preclinical
Duragesic
CCephalon
Preclinical
Prolia
OOrganon and Co
Preclinical
Oxycontin
PProtega
Preclinical
Prograf
VVeloxis Pharmaceuticals
Preclinical
Neurontin
VViatris Specialty LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Cephazolin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- HHaEmek Medical Center, Israel